Early Rule Out of Myocardial Infarction With a Novel High-Sensitivity Cardiac Troponin T Assay

Area of Science:

• Cardiology and Emergency Medicine
• Biomarker Assay Development
• Clinical Risk Stratification

Background:

• Accurate identification of low-risk myocardial infarction (MI) patients in emergency departments is crucial for efficient care.
• High-sensitivity cardiac troponin T (hs-cTnT) assays are vital tools for MI rule-out.
• Advancements in assay technology, such as the sixth-generation hs-cTnT, aim to improve diagnostic performance.

Purpose of the Study:

• To establish a risk-stratification threshold for the sixth-generation hs-cTnT assay.
• To evaluate the effectiveness of this threshold in an early MI rule-out pathway.
• To compare the performance of the sixth-generation assay with the fifth-generation assay.

Main Methods:

• Prospective, multicenter cohort study (derivation and validation cohorts).
• Analysis of cardiac troponin T concentrations using fifth and sixth-generation hs-cTnT assays.
• Determination of thresholds for MI risk stratification based on negative predictive value (NPV) and sensitivity.

Main Results:

• The sixth-generation hs-cTnT assay identified a significantly higher proportion of low-risk patients (61% vs 17.4% in derivation, 45.4% vs 6.9% in validation).
• A threshold of <13 ng/L for the sixth-generation assay demonstrated high NPV (≥99.0%) and sensitivity (≥97.5%) for 30-day major adverse cardiac events.
• The sixth-generation assay doubled the identification of patients suitable for early discharge or rule-out pathways.

Conclusions:

• The sixth-generation hs-cTnT assay, with an appropriate threshold, significantly enhances the identification of low-risk MI patients.
• This improved identification can optimize early rule-out strategies in emergency settings.
• Further prospective studies are needed to assess the clinical implementation impact.